These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 21371510)

  • 21. A new intranasal influenza vaccine based on a novel polycationic lipid--ceramide carbamoyl-spermine (CCS) I. Immunogenicity and efficacy studies in mice.
    Joseph A; Itskovitz-Cooper N; Samira S; Flasterstein O; Eliyahu H; Simberg D; Goldwaser I; Barenholz Y; Kedar E
    Vaccine; 2006 May; 24(18):3990-4006. PubMed ID: 16516356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dry powder vaccines for mucosal administration: critical factors in manufacture and delivery.
    Wang SH; Thompson AL; Hickey AJ; Staats HF
    Curr Top Microbiol Immunol; 2012; 354():121-56. PubMed ID: 21822816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Devices for intradermal vaccination.
    Kis EE; Winter G; Myschik J
    Vaccine; 2012 Jan; 30(3):523-38. PubMed ID: 22100637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dry-coated live viral vector vaccines delivered by nanopatch microprojections retain long-term thermostability and induce transgene-specific T cell responses in mice.
    Pearson FE; McNeilly CL; Crichton ML; Primiero CA; Yukiko SR; Fernando GJ; Chen X; Gilbert SC; Hill AV; Kendall MA
    PLoS One; 2013; 8(7):e67888. PubMed ID: 23874462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel prototype device for electroporation-enhanced DNA vaccine delivery simultaneously to both skin and muscle.
    Lin F; Shen X; McCoy JR; Mendoza JM; Yan J; Kemmerrer SV; Khan AS; Weiner DB; Broderick KE; Sardesai NY
    Vaccine; 2011 Sep; 29(39):6771-80. PubMed ID: 21199706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Needle-free skin patch delivery of a vaccine for a potentially pandemic influenza virus provides protection against lethal challenge in mice.
    Garg S; Hoelscher M; Belser JA; Wang C; Jayashankar L; Guo Z; Durland RH; Katz JM; Sambhara S
    Clin Vaccine Immunol; 2007 Jul; 14(7):926-8. PubMed ID: 17494637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. "IDEAL" vaccines for resource poor settings.
    Levine MM
    Vaccine; 2011 Dec; 29 Suppl 4():D116-25. PubMed ID: 22486974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AF03-adjuvanted and non-adjuvanted pandemic influenza A (H1N1) 2009 vaccines induce strong antibody responses in seasonal influenza vaccine-primed and unprimed mice.
    Caillet C; Piras F; Bernard MC; de Montfort A; Boudet F; Vogel FR; Hoffenbach A; Moste C; Kusters I
    Vaccine; 2010 Apr; 28(18):3076-9. PubMed ID: 20193791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dry coating of immunotherapeutics to densely packed and short microprojection arrays.
    Park K
    J Control Release; 2009 Nov; 139(3):171. PubMed ID: 19735682
    [No Abstract]   [Full Text] [Related]  

  • 30. Pulmonary vaccine delivery.
    Lu D; Hickey AJ
    Expert Rev Vaccines; 2007 Apr; 6(2):213-26. PubMed ID: 17408371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel dry powder influenza vaccine and intranasal delivery technology: induction of systemic and mucosal immune responses in rats.
    Huang J; Garmise RJ; Crowder TM; Mar K; Hwang CR; Hickey AJ; Mikszta JA; Sullivan VJ
    Vaccine; 2004 Dec; 23(6):794-801. PubMed ID: 15542204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcutaneous vaccines: novel advances in technology and delivery for overcoming the barriers.
    Li N; Peng LH; Chen X; Nakagawa S; Gao JQ
    Vaccine; 2011 Aug; 29(37):6179-90. PubMed ID: 21740946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenicity and safety of low dose virosomal adjuvanted influenza vaccine administered intradermally compared to intramuscular full dose administration.
    Künzi V; Klap JM; Seiberling MK; Herzog C; Hartmann K; Kürsteiner O; Kompier R; Grimaldi R; Goudsmit J
    Vaccine; 2009 Jun; 27(27):3561-7. PubMed ID: 19464535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulmonary delivery of an inulin-stabilized influenza subunit vaccine prepared by spray-freeze drying induces systemic, mucosal humoral as well as cell-mediated immune responses in BALB/c mice.
    Amorij JP; Saluja V; Petersen AH; Hinrichs WL; Huckriede A; Frijlink HW
    Vaccine; 2007 Dec; 25(52):8707-17. PubMed ID: 17996993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advances in transcutaneous vaccine delivery: do all ways lead to Rome?
    Bal SM; Ding Z; van Riet E; Jiskoot W; Bouwstra JA
    J Control Release; 2010 Dec; 148(3):266-82. PubMed ID: 20869998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: biological properties and immunogenicity in a mouse model.
    Amidi M; Romeijn SG; Verhoef JC; Junginger HE; Bungener L; Huckriede A; Crommelin DJ; Jiskoot W
    Vaccine; 2007 Jan; 25(1):144-53. PubMed ID: 16973248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of delivery parameters on immunization to ovalbumin following intracutaneous administration by a coated microneedle array patch system.
    Widera G; Johnson J; Kim L; Libiran L; Nyam K; Daddona PE; Cormier M
    Vaccine; 2006 Mar; 24(10):1653-64. PubMed ID: 16246466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Priming with AS03 A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised extension of a double-blind randomised primary study.
    Leroux-Roels I; Roman F; Forgus S; Maes C; De Boever F; Dramé M; Gillard P; van der Most R; Van Mechelen M; Hanon E; Leroux-Roels G
    Vaccine; 2010 Jan; 28(3):849-57. PubMed ID: 19835828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Administration routes affect the quality of immune responses: A cross-sectional evaluation of particulate antigen-delivery systems.
    Mohanan D; Slütter B; Henriksen-Lacey M; Jiskoot W; Bouwstra JA; Perrie Y; Kündig TM; Gander B; Johansen P
    J Control Release; 2010 Nov; 147(3):342-9. PubMed ID: 20727926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Needle-free epidermal powder immunization.
    Chen D; Maa YF; Haynes JR
    Expert Rev Vaccines; 2002 Oct; 1(3):265-76. PubMed ID: 12901567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.